Compare CSTL & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSTL | MCFT |
|---|---|---|
| Founded | 2007 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Marine Transportation |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 722.8M | 597.3M |
| IPO Year | 2019 | 2015 |
| Metric | CSTL | MCFT |
|---|---|---|
| Price | $28.00 | $23.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $45.50 | $24.25 |
| AVG Volume (30 Days) | ★ 290.0K | 112.0K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.33 |
| Revenue | ★ $344,229,000.00 | $284,203,000.00 |
| Revenue This Year | $2.42 | $9.18 |
| Revenue Next Year | $12.69 | $8.23 |
| P/E Ratio | ★ N/A | $74.82 |
| Revenue Growth | ★ 3.66 | N/A |
| 52 Week Low | $14.59 | $17.19 |
| 52 Week High | $44.28 | $28.44 |
| Indicator | CSTL | MCFT |
|---|---|---|
| Relative Strength Index (RSI) | 75.45 | 46.01 |
| Support Level | $22.67 | $23.21 |
| Resistance Level | $34.97 | $24.09 |
| Average True Range (ATR) | 1.31 | 0.90 |
| MACD | 0.33 | -0.07 |
| Stochastic Oscillator | 84.88 | 19.40 |
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.